(VIANEWS) – GOLDEN OCEAN GROUP (GOGL.OL), VASTNED BELGIUM (VASTB.BR), SPBK1 RINGERIKE (RING.OL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. GOLDEN OCEAN GROUP (GOGL.OL)
102.62% Payout Ratio
Golden Ocean Group Limited, a shipping company, owns and operates a fleet of dry bulk vessels worldwide. It operates dry bulk vessels comprising of Newcastlemax, Capesize, Panamax, and Ultramax vessels in the spot and time charter markets. The company's vessels transport a range of bulk commodities, such as ores, coal, grains, and fertilizers. As of March 16, 2023, it owned a fleet of 74 dry bulk vessels. The company is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, GOLDEN OCEAN GROUP has a trailing twelve months EPS of kr23.61.
PE Ratio
GOLDEN OCEAN GROUP has a trailing twelve months price to earnings ratio of 4.11. Meaning, the purchaser of the share is investing kr4.11 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.02%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 33.5%, now sitting on 1.11B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 16.43 and the estimated forward annual dividend yield is 16.67%.
Yearly Top and Bottom Value
GOLDEN OCEAN GROUP’s stock is valued at kr96.96 at 22:10 EST, way below its 52-week high of kr156.55 and way higher than its 52-week low of kr78.50.
More news about GOLDEN OCEAN GROUP.
2. VASTNED BELGIUM (VASTB.BR)
78.85% Payout Ratio
Vastned Retail Belgium is a public regulated real estate company (RREC), the shares of which are listed on Euronext Brussels (VASTB). Vastned Retail Belgium invests exclusively in Belgian commercial real estate, more specifically in prime retail properties located on the best shopping streets in the major cities of Antwerp, Brussels, Ghent and Bruges. Furthermore, the real estate portfolio consists of inner-city shops outside of the premium cities, high-end retail parks and retail warehouses.
Earnings Per Share
As for profitability, VASTNED BELGIUM has a trailing twelve months EPS of €2.79.
PE Ratio
VASTNED BELGIUM has a trailing twelve months price to earnings ratio of 10.82. Meaning, the purchaser of the share is investing €10.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.29%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 2.25 and the estimated forward annual dividend yield is 7.38%.
Moving Average
VASTNED BELGIUM’s worth is below its 50-day moving average of €30.87 and higher than its 200-day moving average of €30.02.
More news about VASTNED BELGIUM.
3. SPBK1 RINGERIKE (RING.OL)
63.98% Payout Ratio
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr25.31.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 13.28. Meaning, the purchaser of the share is investing kr13.28 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.9%.
Sales Growth
SPBK1 RINGERIKE’s sales growth is 10.2% for the current quarter and 11.1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 32.2% and 37.6%, respectively.
More news about SPBK1 RINGERIKE.
4. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €2.15.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 40.38. Meaning, the purchaser of the share is investing €40.38 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
Sales Growth
UCB’s sales growth for the current quarter is negative 4.6%.
More news about UCB.
5. VOSS VEKSEL OGLAND (VVL.OL)
45.23% Payout Ratio
Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.
Earnings Per Share
As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr23.62.
PE Ratio
VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 9.99. Meaning, the purchaser of the share is investing kr9.99 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.24%.
Volume
Today’s last reported volume for VOSS VEKSEL OGLAND is 205 which is 34.71% below its average volume of 314.
More news about VOSS VEKSEL OGLAND.
6. SPAREBANKEN VEST (SVEG.OL)
43.73% Payout Ratio
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. The company was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr10.29.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 9.15. Meaning, the purchaser of the share is investing kr9.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.51%.
Yearly Top and Bottom Value
SPAREBANKEN VEST’s stock is valued at kr94.20 at 22:10 EST, under its 52-week high of kr103.60 and way above its 52-week low of kr77.70.
Moving Average
SPAREBANKEN VEST’s worth is below its 50-day moving average of kr95.41 and higher than its 200-day moving average of kr90.40.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 23, 2023, the estimated forward annual dividend rate is 5.5 and the estimated forward annual dividend yield is 5.98%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 9.4% and 35.3%, respectively.
More news about SPAREBANKEN VEST.
